UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform

PloS one, 2013-10, Vol.8 (10), p.e75518-e75518

2013

Link zum Volltext

Verfügbarkeit prüfen

First-in-human phase I study of PRS-050 (Angiocal), an Anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors

PloS one, 2013-12, Vol.8 (12), p.e83232

2013

Link zum Volltext

Verfügbarkeit prüfen

Identification of Proangiogenic Genes and Pathways by High-Throughput Functional Genomics: TBK1 and the IRF3 Pathway

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (11), p.4240-4245

2006

Link zum Volltext

Verfügbarkeit prüfen

Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins

PloS one, 2014-05, Vol.9 (5), p.e94972-e94972

2014

Link zum Volltext

Verfügbarkeit prüfen

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration

The EMBO journal, 2000-08, Vol.19 (15), p.4064-4073

2000

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter

Nature (London), 1992-07, Vol.358 (6385), p.414-417

1992

Link zum Volltext

Verfügbarkeit prüfen

Activation of ternary complex factor Elk-1 by stress-activated protein kinases

Current biology, 1995-10, Vol.5 (10), p.1191-1200

1995

Link zum Volltext

Verfügbarkeit prüfen

Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma

Journal of allergy and clinical immunology, 2023-04, Vol.151 (4), p.966-975

2023

Link zum Volltext

Verfügbarkeit prüfen

Sustained plasma hepcidin suppression and iron elevation by Anticalin‐derived hepcidin antagonist in cynomolgus monkey

British journal of pharmacology, 2018-04, Vol.175 (7), p.1054-1065

2018

Link zum Volltext

Verfügbarkeit prüfen

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

The Journal of biological chemistry, 2001-02, Vol.276 (5), p.3222-3230

2001

Link zum Volltext

Verfügbarkeit prüfen

Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class

Angiogenesis (London), 2016-01, Vol.19 (1), p.79-94

2016

Link zum Volltext

Verfügbarkeit prüfen

Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression

The Journal of biological chemistry, 1999-07, Vol.274 (31), p.22033-22040

1999

Link zum Volltext

Verfügbarkeit prüfen

A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity

Molecular cancer therapeutics, 2013-11, Vol.12 (11), p.2459-2471

2013

Link zum Volltext

Verfügbarkeit prüfen

ERK phosphorylation potentiates Elk‐1‐mediated ternary complex formation and transactivation

The EMBO journal, 1995-03, Vol.14 (5), p.951-962

1995

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)

The Journal of biological chemistry, 2001-02, Vol.276 (5), p.3222-3230

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3875: Exploiting the Anticalin therapeutic protein platform for the treatment of cMet ligand-independent and dependent tumors - discovery and characterization of a highly specific and potent c-Met antagonist with drug-like properties

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3875-3875

2012

Link zum Volltext

Verfügbarkeit prüfen

Discovery and Preclinical Characterization of a Novel Hepcidin Antagonist with Tunable PK/PD Properties for the Treatment of Anemia in Different Patient Populations

Blood, 2011-11, Vol.118 (21), p.687-687

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3621: A monovalent Anticalin antagonist: A novel approach for inhibition of c-Met-dependent tumor growth

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3621-3621

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3632: Nonclinical pharmacokinetics and safety of Angiocal, the first VEGF-A-specific alternative scaffold protein entering clinical development for cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3632-3632

2011

Link zum Volltext

Verfügbarkeit prüfen

Development of secreted proteins as biotherapeutic agents

Expert opinion on biological therapy, 2004-04, Vol.4 (4), p.551-558

2004

Link zum Volltext

Verfügbarkeit prüfen

Localized DNA melting and structural pertubations in the origin of replication, oriC, of Escherichia coli in vitro and in vivo

The EMBO journal, 1991-06, Vol.10 (6), p.1579-1584

1991

Link zum Volltext

Verfügbarkeit prüfen

Selective Response of Ternary Complex Factor Sap1a to Different Mitogen-Activated Protein Kinase Subgroups

Proceedings of the National Academy of Sciences - PNAS, 1996-10, Vol.93 (21), p.11563-11568

1996

Link zum Volltext

Verfügbarkeit prüfen

The FIS protein binds and bends the origin of chromosomal DNA replication, oriC, of Escherichia coli

Nucleic acids research, 1991-08, Vol.19 (15), p.4167-4172

1991

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE

Molecular and Cellular Biology, 1996-03, Vol.16 (3), p.1094-1102

1996

Link zum Volltext

Verfügbarkeit prüfen

Identification of Amino Acids Essential for DNA Binding and Dimerization in p67SRF: Implications for a Novel DNA-Binding Motif

Molecular and cellular biology, 1993-01, Vol.13 (1), p.123-132

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(41)
Tagungsberichte
(1)

Sprache

Englisch
(40)
Japanisch
(11)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform

First-in-human phase I study of PRS-050 (Angiocal), an Anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors

Identification of Proangiogenic Genes and Pathways by High-Throughput Functional Genomics: TBK1 and the IRF3 Pathway

Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration

Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter

Activation of ternary complex factor Elk-1 by stress-activated protein kinases

Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma

Sustained plasma hepcidin suppression and iron elevation by Anticalin‐derived hepcidin antagonist in cynomolgus monkey

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class

Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression

A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity

ERK phosphorylation potentiates Elk‐1‐mediated ternary complex formation and transactivation

Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)

Abstract 3875: Exploiting the Anticalin therapeutic protein platform for the treatment of cMet ligand-independent and dependent tumors - discovery and characterization of a highly specific and potent c-Met antagonist with drug-like properties

Discovery and Preclinical Characterization of a Novel Hepcidin Antagonist with Tunable PK/PD Properties for the Treatment of Anemia in Different Patient Populations

Abstract 3621: A monovalent Anticalin antagonist: A novel approach for inhibition of c-Met-dependent tumor growth

Abstract 3632: Nonclinical pharmacokinetics and safety of Angiocal, the first VEGF-A-specific alternative scaffold protein entering clinical development for cancer

Development of secreted proteins as biotherapeutic agents

Localized DNA melting and structural pertubations in the origin of replication, oriC, of Escherichia coli in vitro and in vivo

Selective Response of Ternary Complex Factor Sap1a to Different Mitogen-Activated Protein Kinase Subgroups

The FIS protein binds and bends the origin of chromosomal DNA replication, oriC, of Escherichia coli

Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE

Identification of Amino Acids Essential for DNA Binding and Dimerization in p67SRF: Implications for a Novel DNA-Binding Motif

Suchergebnisse filtern